Loading provider…
Loading provider…
Neurology Physician in Redlands, CA
NPI: 1003234550Primary Employer
Progressive Neurology & Sleep Medicine Associates
progressiveneuroandsleep.com
HQ Phone
Get MD Pei's Phone Numberphone_androidMobile
Get MD Pei's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2015 - 2025

American Board of Psychiatry and Neurology
Neurology

American Board of Psychiatry and Neurology
Clinical Neurophysiology

Neurocritical Care Society
Emergency Neurologic Life Support
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Fellowship • Clinical Neurophysiology
2018 - 2019
Residency • Neurology
2015 - 2018
University of California (Irvine)
Internship • Transitional Year
2014 - 2015
Drexel University College Of Medicine
drexel.edu
Medical School
Until 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 70 | 130 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 62 | 62 |
| 3 | 95886Needle measurement and recording of electrical activity of muscles of arm or leg complete study | 26 | 58 |
| 4 | 95912Nerve transmission studies, 11-12 studies | 25 | 27 |
Authors: Zhang, Wei, Liu, Pei, Ling, Shifeng, Wang, Fuhua, Wang, Shaojiao, Chen, Tienan, Zhou, Rujiang, Xia, Xuechun, Yao, Zhengju, Fan, Ying, Wang, Niansong, Wang, Jiqiu, Tucker, Haley O, Guo, Xizhi
Journal: J Bone Miner Res
Publication Date: 2021-07-07
Authors: Matthew Burns
Journal: J Neuropathol Exp Neurol
Fluorogenic Targeting of Voltage-Sensitive Dyes to Neurons
Authors: Liu, Pei, Grenier, Vincent, Hong, Wootack, Muller, Vikram R, Miller, Evan W
Journal: J Am Chem Soc
Publication Date: 2017-11-20
Lead Sponsor: UCB Biopharma SRL
Intervention / Treatment: OTHER: Placebo, DRUG: Rozanolixizumab
Lead Sponsor: argenx
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: ARGX-113
Lead Sponsor: Catalyst Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Placebo Oral Tablet, DRUG: Amifampridine Phosphate